Health Canada — Marketed Health Products · Canada · 2002-07-29
As described by Health Canada — Marketed Health Products: Archived – Cochlear Implant Recipients may be at Greater Risk for Meningitis
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Health Canada has become aware of information issued by the US-FDA concerning a possible association between cochlear implants and the occurrence of bacterial meningitis . It was stated in the FDA Public Health Web Notification on July 24/2002 ( http://www.fda.gov/cdrh/safety/cochlear.html ). "At least 25 cases of meningitis have been diagnosed worldwide in children and adults ranging in age from 21 months to 63 years who have undergone cochlear implantation for severe to profound deafness. A total of 9 known deaths resulted from these cases. At this time, 2 out of 3 companies have reported cases of bacterial meningitis in patients who have been implanted.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.